Note 8 - Stockholders' Equity

9 Months Ended

Sep. 30, 2024

Notes to Financial Statements

Equity [Text Block]

Note 8. Stockholders’ Equity

Effective on April 21, 2023, the Company filed a Certificate of Change to the Articles of Incorporation to effect the Reverse Stock Split (see Note 1). All share and per share information in this Quarterly Report on Form 10-Q have been retroactively adjusted to reflect the Reverse Stock Split.

The changes in condensed consolidated stockholders’ equity for the three and nine months ended September 30, 2024, and 2023, are as follows:

	Common		Common		Additional
	Stock		Stock		Paid-In			Accumulated			Treasury
	Shares		Amount		Capital			Deficit			Stock			Total
Balance at December 31, 2023		3,867,082	$	2,320	$	48,602		$	(24,209	)	$	(5,402	)	$	21,311
Common stock issued under restricted stock units		4,710		3		(3	)		—			—			—
Share-based compensation expense-stock options		—		—		55			—			—			55
Share-based compensation expense-restricted stock units		—		—		121			—			—			121
Treasury shares		—		—		—			—			(651	)		(651	)
Net income		—		—		—			681			—			681
Balance at March 31, 2024		3,871,792		2,323		48,775			(23,528	)		(6,053	)		21,517
Common stock issued under restricted stock units		6,006		4		(4	)		—			—			—
Share-based compensation expense-stock options		—		—		77			—			—			77
Share-based compensation expense-restricted stock units		—		—		148			—			—			148
Net income		—		—		—			1,664			—			1,664
Balance at June 30, 2024		3,877,798		2,327		48,996			(21,864	)		(6,053	)		23,406
Common stock issued under restricted stock units		21,327		12		(12	)		—			—			—
Common stock issued - exercised warrants		6,018		4		(4	)		—			—			—
Share-based compensation expense-stock options		—		—		78			—			—			78
Share-based compensation expense-restricted stock units		—		—		146			—			—			146
Net income		—		—		—			2,357			—			2,357
Balance at September 30, 2024		3,905,143	$	2,343	$	49,204		$	(19,507	)	$	(6,053	)	$	25,987

	Common		Common		Additional
	Stock		Stock		Paid-In			Accumulated			Treasury
	Shares		Amount		Capital			Deficit			Stock			Total
Balance at December 31, 2022		3,686,939	$	2,212	$	45,304		$	(21,979	)	$	(5,402	)	$	20,135
Common stock issued		858		1		14			—			—			15
Common stock issued under restricted stock units		1,920		1		(1	)		—			—			—
Share-based compensation expense-stock options		—		—		58			—			—			58
Share-based compensation expense-restricted stock units		—		—		69			—			—			69
Net loss		—		—		—			(1,270	)		—			(1,270	)
Balance at March 31, 2023		3,689,717		2,214		45,444			(23,249	)		(5,402	)		19,007
Common stock issued		2,661		2		33			—			—			35
Common stock issued under restricted stock units		1,920		1		(1	)		—			—			—
Share-based compensation expense-stock options		—		—		61			—			—			61
Share-based compensation expense-restricted stock units		—		—		63			—			—			63
Net loss		—		—		—			(1,340	)		—			(1,340	)
Balance at June 30, 2023		3,694,298		2,217		45,600			(24,589	)		(5,402	)		17,826
Common stock issued		1,254		1		12			—			—			13
Common stock issued under restricted stock units		27,418		16		(16	)		—			—			—
Share-based compensation expense-stock options		—		—		44			—			—			44
Share-based compensation expense-restricted stock units		—		—		641			—			—			641
Net loss		—		—		—			90			—			90
Balance at September 30, 2023		3,722,970	$	2,234	$	46,281		$	(24,499	)	$	(5,402	)	$	18,614